These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 3405196

  • 1. [Malignancy grading in breast cancer as assessed by nuclear DNA content].
    Nishi T, Okajima K, Taguchi T, Mizutani H, Sogabe T, Uragami I, Sekimoto T.
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):576-81. PubMed ID: 3405196
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic significance of nuclear DNA content in breast cancer].
    Nishi T, Okajima K, Taguchi T, Ryo T, Mizutani H, Kawashima Y, Sekimoto T.
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar 20; 25(3):569-77. PubMed ID: 2351850
    [Abstract] [Full Text] [Related]

  • 3. [Clinical significance of measurement of nuclear DNA content in breast cancer].
    Nishi T, Okajima K, Taguchi T, Ryo T, Sekimoto T.
    Nihon Geka Gakkai Zasshi; 1989 Sep 20; 90(9):1559-63. PubMed ID: 2586466
    [Abstract] [Full Text] [Related]

  • 4. [Nuclear DNA content in breast cancer in relation to postoperative recurrence].
    Nishi T, Okajima K, Taguchi T, Ryo T, Osada K, Kanemoto H.
    Nihon Geka Gakkai Zasshi; 1991 Apr 20; 92(4):459-63. PubMed ID: 1870575
    [Abstract] [Full Text] [Related]

  • 5. [A study of DNA ploidy patterns of gastric cancers].
    Yoshino H.
    Nihon Geka Gakkai Zasshi; 1988 Apr 20; 89(4):522-33. PubMed ID: 3405194
    [Abstract] [Full Text] [Related]

  • 6. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
    Theissig F, Kunze KD, Haroske G, Meyer W, Dimmer V.
    Zentralbl Chir; 1990 Apr 20; 115(7):433-9. PubMed ID: 2164288
    [Abstract] [Full Text] [Related]

  • 7. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D.
    Cancer Res; 1984 Sep 20; 44(9):4187-96. PubMed ID: 6744328
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T, Lamovec J, Bracko M, Lindtner J, Us-Krasovec M.
    Neoplasma; 1997 Sep 20; 44(2):127-32. PubMed ID: 9201293
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW, Zarbo RJ, Greenawald KA, Crissman JD.
    Pathol Annu; 1990 Sep 20; 25 Pt 1():171-210. PubMed ID: 2153277
    [Abstract] [Full Text] [Related]

  • 10. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU, Fallenius AG, Erhardt KY, Sundelin BS.
    Cytometry; 1984 Jul 20; 5(4):420-5. PubMed ID: 6468180
    [Abstract] [Full Text] [Related]

  • 11. DNA ploidy and TLI in association with other prognostic parameters in breast cancer.
    Midulla C, Cenci M, De Iorio P, Pisani T, Bonaccorsi A, De Marchis L, Nofroni I, Vecchione A.
    Anticancer Res; 1999 Jul 20; 19(1A):381-4. PubMed ID: 10226571
    [Abstract] [Full Text] [Related]

  • 12. Use of nuclear image cytometry, histopathological grading and DNA cytometry to make breast cancer prognosis more objective.
    Theissig F, Dimmer V, Haroske G, Kunze KD, Meyer W.
    Anal Cell Pathol; 1991 Nov 20; 3(6):351-60. PubMed ID: 1751402
    [Abstract] [Full Text] [Related]

  • 13. An improved prognostic index of axillary node involvement in breast cancer incorporating DNA ploidy and tumour size.
    Eskelinen M, Collan Y, Pajarinen P, Pesonen E, Kettunen K, Nordling S.
    Acta Chir Scand; 1990 Aug 20; 156(8):521-7. PubMed ID: 2239052
    [Abstract] [Full Text] [Related]

  • 14. [DNA ploidy in submucosal cancer of the stomach and its relationship to lymph node metastasis].
    Hashizume T, Yamaura T, Fukuda T, Sugihara S, Nakajima T, Nagamachi Y.
    Nihon Geka Gakkai Zasshi; 1991 Apr 20; 92(4):397-400. PubMed ID: 1870567
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
    Noguchi M, Ota N, Koyazaki N, Taniya T, Miyazaki I, Mizukami Y.
    Nihon Geka Gakkai Zasshi; 1992 Mar 20; 93(3):295-9. PubMed ID: 1513310
    [Abstract] [Full Text] [Related]

  • 16. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec 20; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
    Jpn J Clin Oncol; 2005 Mar 20; 35(3):126-33. PubMed ID: 15741302
    [Abstract] [Full Text] [Related]

  • 18. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J.
    Ai Zheng; 2005 Mar 20; 24(3):327-31. PubMed ID: 15757535
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of cathepsin-D expression in female breast cancer.
    Aaltonen M, Lipponen P, Kosma VM, Aaltomaa S, Syrjänen K.
    Anticancer Res; 1995 Mar 20; 15(3):1033-7. PubMed ID: 7645922
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
    Bergers E, Baak JP, van Diest PJ, Willig AJ, Los J, Peterse JL, Ruitenberg HM, Schapers RF, Somsen JG, van Beek MW, Bellot SM, Fijnheer J, van Gorp LH.
    Mod Pathol; 1997 Aug 20; 10(8):762-8. PubMed ID: 9267817
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.